PSNL
Price:
$4.405
Market Cap:
$311.20M
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or plasma sample; ImmunoID Next for tumor profiling from tissue; NeXT Liquid Biopsy for tumor profiling from plasma; NeXT Personal, a liquid biopsy offering for personalized tumor tracking for patients; NeXT Dx Test, a genomic cancer profiling test enabling composite biomarkers for cancer treatment; and NeXT SHERPA and NeXT NEOPS for neoantigen prediction c...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2019-06-20
Stock Exchange
NASDAQ
Ticker
PSNL
According to Personalis, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -2.81. This represents a change of 97.02% compared to the average of -1.43 of the last 4 quarters.
The mean historical PE Ratio of Personalis, Inc. over the last ten years is -16.72. The current -2.81 PE Ratio has changed 1.58% with respect to the historical average. Over the past ten years (40 quarters), PSNL's PE Ratio was at its highest in in the September 2023 quarter at -0.51. The PE Ratio was at its lowest in in the December 2018 quarter at -43.59.
Average
-16.72
Median
-13.58
Minimum
-34.68
Maximum
-0.80
Discovering the peaks and valleys of Personalis, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 155.46%
Maximum Annual PE Ratio = -0.80
Minimum Annual Increase = -91.68%
Minimum Annual PE Ratio = -34.68
Year | PE Ratio | Change |
---|---|---|
2023 | -0.93 | 16.97% |
2022 | -0.80 | -91.68% |
2021 | -9.60 | -72.32% |
2020 | -34.68 | 155.46% |
2019 | -13.58 | -56.44% |
2018 | -31.17 | 18.67% |
The current PE Ratio of Personalis, Inc. (PSNL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.78
5-year avg
-11.92
10-year avg
-16.72
Personalis, Inc.’s PE Ratio is greater than Twist Bioscience Corporation (-10.66), greater than Natera, Inc. (-89.75), greater than Guardant Health, Inc. (-7.44), less than Castle Biosciences, Inc. (143.53), greater than Sera Prognostics, Inc. (-6.93), greater than CareDx, Inc (-7.98), less than Genetron Holdings Limited (0), greater than DarioHealth Corp. (-4.21), less than Invitae Corporation (-0.00), less than Charles River Laboratories International, Inc. (24.88), greater than Illumina, Inc. (-14.44), less than Burning Rock Biotech Limited (-0.49), less than Neuronetics, Inc. (-0.54), greater than Myriad Genetics, Inc. (-7.23),
Company | PE Ratio | Market cap |
---|---|---|
-10.66 | $2.37B | |
-89.75 | $19.25B | |
-7.44 | $3.83B | |
143.53 | $877.19M | |
-6.93 | $218.81M | |
-7.98 | $1.16B | |
0 | $127.29M | |
-4.21 | $27.28M | |
-0.00 | $5.44M | |
24.88 | $10.22B | |
-14.44 | $22.83B | |
-0.49 | $38.85M | |
-0.54 | $19.77M | |
-7.23 | $1.43B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Personalis, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Personalis, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Personalis, Inc.'s PE Ratio?
How is the PE Ratio calculated for Personalis, Inc. (PSNL)?
What is the highest PE Ratio for Personalis, Inc. (PSNL)?
What is the 3-year average PE Ratio for Personalis, Inc. (PSNL)?
What is the 5-year average PE Ratio for Personalis, Inc. (PSNL)?
How does the current PE Ratio for Personalis, Inc. (PSNL) compare to its historical average?